Utah recalls
3,538 federal recalls affecting Utah in the last 12 months - 190 Utah-specific plus 3,348 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International CVC kits recalled for contaminated anesthetic
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple central venous catheter kits. The supplier's components may not be sterile or effective, which could cause serious infection or treatment failure in patients receiving these kits.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International pacing kit recalled for anesthetic sterility risk
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in pacing/PSI kits. The supplier's products had limited reports of drug ineffectiveness, and if the sterility of these injectable products is compromised, it could cause serious or life-threatening injury. Approximately 95 kits were distributed nationwide.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International medical kits recalled for compromised anesthetic sterility
Arrow International included anesthetic medications (lidocaine and bupivacaine) and saline solution from a supplier with quality issues in multiple drainage, thoracentesis, and pneumothorax kits. If these injectable products lost sterility during manufacturing or storage, they could cause serious infection or treatment failure.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International hemodialysis kit recalled for sterility issues
Arrow International hemodialysis kits contain anesthetic and saline solutions from a supplier with quality control problems and reports of drug ineffectiveness. If the sterility of these injectable products is compromised, patients could face serious or life-threatening complications.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International peritoneal lavage kits recalled for sterility risk
Arrow International's 8FR peritoneal lavage catheter kits contain anesthetic medications (lidocaine and bupivacaine) from a supplier with known quality issues. If the sterility of these injectable components is compromised, patients could face serious injury or infection.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International JACC kits recalled for contaminated injectables
Arrow International JACC catheter kits contain lidocaine, bupivacaine, and sodium chloride from a supplier with quality control problems. The injectable components may not work properly or could be sterile-compromised, risking serious infection if used.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International catheter kits recalled for contaminated components
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple PICC and JACC catheter kits. The anesthetic and saline components may be ineffective or contaminated, which could cause serious infection or other life-threatening complications if used.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International catheter kits recalled for contaminated components
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple catheter and arterial line kits. The supplier's products showed signs of ineffectiveness and potential sterility problems, which could cause serious harm if compromised injectable products are used.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International CVC kits recalled for contaminated anesthetic drugs
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality problems in multiple central venous catheter kits. The supplier's products had reports of ineffectiveness, and if sterility is compromised, these injectable drugs could cause serious infection or other life-threatening complications.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International CVC kits recalled for sterility concerns
Arrow International included anesthetic and saline components from a supplier with quality issues in several percutaneous central venous catheter (CVC) kits. The supplier's products showed limited reports of drug ineffectiveness, and compromised sterility in injectable products could cause serious injury.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International catheter kits recalled for sterility concerns
Arrow International included injectable medications (lidocaine, bupivacaine, and sodium chloride) from a supplier with quality issues in several catheter kit models. If the sterility of these water-based injectable products is compromised, patients could face serious or life-threatening infections.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International hemodialysis kits recalled for contaminated solutions
Arrow International hemodialysis kits contain lidocaine, bupivacaine, and saline solution from a supplier with quality control problems. The contaminated materials may not work as intended, and compromised sterility in injectable products could cause serious harm to patients.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International hemodialysis kits recalled for sterility issues
Arrow International included injectable medications (lidocaine, bupivacaine, and sodium chloride) from a supplier with quality problems into hemodialysis kits. The supplier's products may not be sterile or effective, which could cause serious injury if used.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International epidural kits recalled for sterility concerns
Arrow International included anesthetic medications (lidocaine, bupivacaine) and saline from a supplier with quality issues in multiple epidural catheter kits. The supplier's products may not be sterile or effective, and compromised sterility in injectable products can cause serious infection or other life-threatening complications.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International PICC kits recalled for contaminated anesthetic components
Arrow International included lidocaine, bupivacaine, and saline solution from a supplier with quality issues in multiple PICC (peripherally inserted central catheter) kit models. The supplier's products may be ineffective or contaminated, and compromised sterility in injectable products can cause serious infection or injury.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International catheter kits recalled for sterility risk
Arrow International recalled multiple central venous catheter kits that contain lidocaine, bupivacaine, and saline solution from a supplier with quality issues. The supplier's products may have compromised sterility, which could reduce drug effectiveness and pose serious health risks if the injectable solution is contaminated.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International catheter kits recalled for drug quality issues
Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with known quality problems in multiple arterial and radial artery catheter kits. The supplier's medications showed signs of ineffectiveness, and if the sterility of these injectable products was compromised, patients could face serious injury.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International PICC kits recalled for sterility concerns
Arrow International recalled several PICC (peripherally inserted central catheter) kits and stylets because they contain injectable medications from a supplier with quality issues. The medications—lidocaine, bupivacaine, and saline—may be ineffective or contaminated, which could cause serious injury if used.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International Pacing PSI Kits recalled for sterility and drug concerns
Arrow International included local anesthetic drugs (lidocaine and bupivacaine) from a supplier with quality issues into several pacing procedure kits. The supplier's drugs had limited reports of ineffectiveness, and compromised sterility in injectable products could cause serious infection or other life-threatening complications.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International biopsy kits recalled for anesthetic sterility issues
Arrow International included anesthetic medications (lidocaine and bupivacaine) and saline solution from a supplier with quality problems in its biopsy system kits. The supplier had reports of drug ineffectiveness, and compromised sterility in injectable products could cause serious injury.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International anesthesia kits recalled for contaminated solutions
Arrow International included lidocaine, bupivacaine, and saline solutions from a supplier with quality problems in multiple anesthesia and nerve block kits. The supplier's products may be ineffective or contaminated, which could cause serious infection or other life-threatening complications if the sterility of these injectable solutions is compromised.
- 2026-06-24FDA-DeviceArrowClass INationwideArrow International paracentesis kits recalled for sterility risk
Arrow International paracentesis kits (models AK-00376 and ASK-00376-VCU) contain anesthetic and saline solutions from a supplier with quality issues and reports of drug ineffectiveness. If the sterility of these injectable products is compromised, they could cause serious or life-threatening infections or complications during the procedure.
- 2026-06-24FDA-DeviceAbiomedClass INationwideAbiomed Impella Controller recalled for software error
A software error in certain Automated Impella Controller devices (used to manage left heart support blood pumps) may affect device function. The error affects controllers with software versions 6.0.1, 6.0.2, 6.0.3, 7.1 and above across multiple regions worldwide.
- 2026-06-24FDA-DeviceDatex-OhmedaClass INationwideDatex-Ohmeda Panda warmer recalled for oxygen concentration error
A blender component in certain Datex-Ohmeda Panda Freestanding Warmers can loosen over time, causing the device to deliver oxygen at a concentration that does not match the setting the user selected. This can result in infants receiving too much or too little oxygen, potentially causing harm.
- 2026-06-24FDA-DeviceDatex-OhmedaClass INationwideDatex-Ohmeda infant warmers recalled for oxygen delivery risk
A component in certain Giraffe and Panda warming systems can loosen during maintenance, causing the device to deliver oxygen at a concentration different from what the clinician set. This can result in too much oxygen (hyperoxia) or too little oxygen (hypoxia) being delivered to the patient.
- 2026-06-24FDA-DeviceDatex-OhmedaClass INationwideDatex-Ohmeda Giraffe resuscitator recalled for oxygen delivery risk
A component in certain Giraffe Stand-alone Infant Resuscitation Systems can loosen during maintenance, causing the device to deliver oxygen at the wrong concentration. Infants may receive too much or too little oxygen, risking serious harm.
- 2026-06-24FDA-FoodDkiruClass IINationwideAdndale Magnesium Glycinate Gummies recalled for undeclared melatonin
Dkiru LLC's Adndale Magnesium Glycinate Gummies 400 mg contain melatonin that is not listed on the label. The affected product is sold in 90-count plastic bottles (UPC 860008784551) with three affected lot numbers expiring between August and September 2026. Melatonin is a sleep aid not declared in the ingredient list, which poses a risk to consumers who may not expect it or who should avoid it due to other medications or health conditions.
- 2026-06-24FDA-FoodUnited States BakeryClass IIGreat Value Hawaiian Rolls recalled for packaging contamination
Great Value Hawaiian Roll 4-packs were found to have an oily and sticky substance on the food-contact surface of the packaging. The affected product was identified at wholesale distribution centers before reaching store shelves, and all units have been accounted for.
- 2026-06-24FDA-FoodMid DolciariaClass IINationwideMid Dolciaria cannoli recalled for unapproved food coloring
Mid Dolciaria .155 Crunchy Cannoli Gluten Free desserts contain chlorophyll colors (E140 and E141) that are not approved for use in the United States. The affected lot was distributed in the USA.
- 2026-06-24FDA-FoodMid DolciariaClass IINationwideMid Dolciaria Cannoli Siciliani recalled for unapproved colors
Mid Dolciaria Cannoli Siciliani dessert boxes contain unapproved food colorings (chlorophyll E140 and E141) that are not permitted in the U.S. The affected product was distributed in the USA with a best-before date of 10/17/2026.
Get notified about new Utah recalls
Free weekly digest. Add Utah to your profile to filter alerts to your state.
Get the Sunday Brief